Mimedx (MDXG) Debt to Equity (2011 - 2026)

Mimedx has disclosed Debt to Equity across 12 years of filings, most recently posting $0.07 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.07, down 21.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.07 (down 21.29% YoY), and the FY2025 annual result was $0.07, down 28.18% from the prior year.
• Debt to Equity came in at $0.07 for Q1 2026 at Mimedx, up from $0.07 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $36.82 in Q3 2023 to a low of -$6.49 in Q1 2022.
• The 5-year median for Debt to Equity is $0.08 (2025), against an average of $0.95.
• Across the five-year window, Debt to Equity sank 100.46% in 2022 and surged 1582.54% in 2023, its largest moves.
• Mimedx's Debt to Equity stood at -$2.7 in 2022, then surged by 112.73% to $0.34 in 2023, then plunged by 71.66% to $0.1 in 2024, then retreated by 28.18% to $0.07 in 2025, then gained by 3.41% to $0.07 in 2026.
• The last three Debt to Equity figures came in at $0.07 (Q1 2026), $0.07 (Q4 2025), and $0.08 (Q3 2025), per Business Quant data.